CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 4 Derivatives Options or other derivatives
- 8-K Event Delisting notice
- 8-K Event Delisting notice · Executive or director change
- SC 13D Stake Beneficial Ownership Report
- D Other Notice of Sales of Unregistered Securities
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 261,756 shares at $3.28 ($858,560)
- 4 Open-market buy Director bought 283,286 shares at $3.28 ($929,178)
- 8-K Event Agreement ended
- 4 Open-market buy 10% owner bought 335,920 shares at $3.28 ($1,101,818)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale
- 8-K Event Delisting notice
- 8-K Event Material agreement · Agreement ended · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Material agreement
Page 12 of 77 · 1,525 filings